Hereditary Atransferrinemia
What is Hereditary Atransferrinemia?
Hereditary atransferrinemia is an extremely rare genetic disorder that affects how your body moves iron through the bloodstream. People with this condition have little to no transferrin, a protein that carries iron to where it needs to go in your body. Without transferrin, iron cannot reach your red blood cells to make hemoglobin, the substance that carries oxygen throughout your body.
This condition is autosomal recessive, which means you need to inherit a faulty gene from both parents to develop it. When iron cannot be transported properly, two serious problems happen at once. First, your red blood cells become pale and unable to carry oxygen well, causing severe anemia. Second, iron builds up in organs like your liver and heart because it has nowhere else to go. This creates a rare situation where your body has too much iron overall but not enough iron in the right places.
Only a few dozen cases have been reported worldwide since the condition was first identified. Early detection through blood testing can help guide treatment to manage both the anemia and the dangerous buildup of iron in tissues.
Symptoms
People with hereditary atransferrinemia typically show symptoms in infancy or early childhood. Common symptoms include:
- Severe anemia causing extreme fatigue and weakness
- Very pale skin and mucous membranes
- Rapid heartbeat or heart problems
- Enlarged liver or spleen
- Growth delays in children
- Dark urine due to excess iron
- Joint pain or bone problems
- Shortness of breath during normal activities
- Frequent infections due to immune system problems
Because this condition is present from birth, symptoms usually appear early in life. Most cases are identified in the first year of life when severe anemia becomes apparent.
Concerned about Hereditary Atransferrinemia? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
Hereditary atransferrinemia is caused by mutations in the TF gene, which provides instructions for making transferrin protein. When both copies of this gene are faulty, your body cannot produce functional transferrin. Without this carrier protein, iron remains trapped in tissues instead of being delivered to bone marrow where red blood cells are made. Parents who each carry one mutated gene typically have no symptoms but can pass the condition to their children.
Risk factors are limited to genetics. Children born to parents who both carry a mutation in the TF gene have a 25% chance of developing the condition. The disorder affects males and females equally and has been reported across different ethnic groups. There are no lifestyle or environmental factors that cause this condition, as it is determined entirely by the genes inherited at conception.
How it's diagnosed
Diagnosing hereditary atransferrinemia starts with blood tests that reveal a specific pattern. The Total Iron Binding Capacity test, or TIBC, measures how much transferrin is available to carry iron. In people with this condition, TIBC is essentially absent or extremely low because they produce little to no transferrin. Blood tests also show severe hypochromic anemia, where red blood cells are unusually pale and small. Serum iron levels and ferritin may be elevated, showing that iron is present but cannot be properly transported.
Rite Aid offers testing that includes TIBC as part of our flagship blood panel. This can help identify abnormal iron transport patterns. Genetic testing can confirm the diagnosis by identifying mutations in the TF gene. Additional tests may measure organ function to check for iron damage to the liver, heart, or other tissues.
Treatment options
Treatment for hereditary atransferrinemia focuses on managing both the anemia and iron overload. Common approaches include:
- Plasma or transferrin infusions to provide the missing carrier protein
- Regular blood transfusions to treat severe anemia
- Iron chelation therapy to remove excess iron from organs
- Monitoring liver and heart function regularly
- Working with a hematologist who specializes in blood disorders
- Genetic counseling for families planning to have children
Treatment is lifelong and requires close medical supervision. Early intervention can prevent serious organ damage from iron buildup. If you or your child shows signs of severe anemia with pale blood cells, see a doctor right away for evaluation.
Concerned about Hereditary Atransferrinemia? Get tested at Rite Aid.
- Simple blood draw at your nearest lab
- Results in days, not weeks
- Share results with your doctor
Frequently asked questions
Hereditary atransferrinemia is a rare genetic disorder where the body cannot make transferrin, a protein that carries iron through the bloodstream. Without transferrin, iron cannot reach red blood cells, causing severe anemia. At the same time, iron builds up in organs like the liver and heart, causing damage.
This condition is extremely rare, with only a few dozen cases reported worldwide. It affects males and females equally and has been identified across different ethnic groups. Because it requires inheriting faulty genes from both parents, most cases occur in families with consanguineous relationships or shared ancestry.
The first signs usually appear in infancy and include severe anemia with extreme paleness, fatigue, and poor growth. Babies may have an enlarged liver or spleen and show signs of heart problems. Blood tests reveal pale, small red blood cells despite high levels of stored iron in the body.
Yes, blood tests are essential for detecting this condition. The Total Iron Binding Capacity test, or TIBC, will be extremely low or absent because transferrin is missing. Other blood tests show severe hypochromic anemia with pale red blood cells and elevated iron storage markers like ferritin.
There is no cure for hereditary atransferrinemia, but it can be managed with treatment. Regular infusions of transferrin or plasma can help transport iron properly. Iron chelation therapy removes excess iron from organs, and blood transfusions treat the anemia. Lifelong medical care is necessary.
This condition follows an autosomal recessive pattern, meaning you need to inherit a faulty TF gene from both parents. Parents who carry one mutated gene are typically healthy but have a 25% chance with each pregnancy of having an affected child. Genetic counseling can help families understand their risks.
Without treatment, hereditary atransferrinemia can be life threatening. Iron buildup damages the liver, heart, and other organs, potentially causing organ failure. Severe anemia reduces oxygen delivery throughout the body, affecting growth and development in children. Early diagnosis and treatment are critical for preventing these complications.
No, hereditary atransferrinemia is present from birth and symptoms typically appear in infancy. Adults cannot develop this condition because it is caused by genes inherited at conception. However, adults may be diagnosed later in life if mild cases were missed during childhood.
Because this is a genetic condition affecting protein production, lifestyle changes cannot cure or prevent it. However, avoiding additional iron intake through supplements or fortified foods is important to reduce iron overload. Regular medical monitoring and adherence to treatment plans are the most important factors in managing this condition.
Yes, family members should consider genetic testing if a relative has hereditary atransferrinemia. Parents and siblings may be carriers of the TF gene mutation even if they have no symptoms. Carrier testing helps families make informed decisions about family planning and understand the risk of passing the condition to future children.